Advertisement

Incidence and Predictors of New-Onset Atrial Fibrillation After Transcatheter Edge-to-Edge Repair of the Mitral Valve (from the Nationwide Readmissions Database)

Published:September 06, 2022DOI:https://doi.org/10.1016/j.amjcard.2022.07.032
      Patients who underwent transcatheter edge-to-edge repair (TEER) for mitral regurgitation with atrial fibrillation (AF) at baseline have higher mortality than those without AF. Data on new-onset AF (NOAF) after TEER are limited. Using the 2016 to 2018 Nationwide Readmissions Database, we identified a cohort of patients who underwent TEER and classified them into 3 groups based on AF presence during the study period. The primary end point was the incidence and timing of NOAF up to 6 months after TEER. Logistic regression modeling identified independent predictors of NOAF at readmission. Of the 6,861patients that underwent TEER, 4,134 (59.9%) had AF at baseline, and 239 (3.5%) developed NOAF. Median time-to-NOAF admission was 47 days (interquartile range 16 to 113), and 37% of patients with NOAF presented within 30 days after TEER. Patients with NOAF experienced costlier and longer index-TEER hospitalization and had more co-morbidities. Chronic kidney disease (odds ratio [OR] 1.51, 95% confidence interval [CI] 1.03 to 2.20), fluid and electrolyte disorders (OR 1.59, 95% CI 1.01 to 2.52), and heart failure (OR 1.86, 95% CI 1.01 to 3.44) were identified as independent predictors of NOAF. Hypertensive complications and heart failure were the leading causes of readmission. In conclusion, those patients that developed NOAF after TEER tended to be an overall sicker group at baseline compared with the remainder of the study cohort. These data, obtained from a nationally representative cohort, highlight a particular group of patients subject to developing NOAF and their association with increased rehospitalization in the post-TEER setting. Predictors of NOAF can be screened for during TEER workup to identify patients at increased risk.

      Graphical abstract

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kaur S
        • Sadana D
        • Patel J
        • Gad M
        • Sankaramangalam K
        • Krishnaswamy A
        • Miyasaka R
        • Harb SC
        • Kapadia SR.
        Atrial fibrillation and transcatheter repair of functional mitral regurgitation: evidence from a meta-regression.
        JACC Cardiovasc Interv. 2020; 13: 2374-2384
        • Arora S
        • Vemulapalli S
        • Stebbins A
        • Ramm CJ
        • Kosinski AS
        • Sorajja P
        • Piccini JP
        • Cavender MA
        • Vavalle JP.
        The prevalence and impact of atrial fibrillation on 1-year outcomes in patients undergoing transcatheter mitral valve repair: results from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
        JACC Cardiovasc Interv. 2019; 12: 569-578
        • Keßler M
        • Pott A
        • Mammadova E
        • Seeger J
        • Wöhrle J
        • Rottbauer W
        • Markovic S.
        Atrial fibrillation predicts long-term outcome after transcatheter edge-to-edge mitral valve repair by MitraClip implantation.
        Biomolecules. 2018; 8: 152
        • Mojoli M
        • Gersh BJ
        • Barioli A
        • Masiero G
        • Tellaroli P
        • D'Amico G
        • Tarantini G.
        Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: a systematic review and meta-analysis.
        Am Heart J. 2017; 192: 64-75
        • Subahi A
        • Munir A
        • Abubakar H
        • Akintoye E
        • Yassin AS
        • Adegbala O
        • Alraies MC
        • Elder M
        • Mohamad T
        • Kaki A
        • Schreiber T.
        The impact of atrial fibrillation on transcatheter mitral valve repair outcomes: a propensity-matched analysis.
        J Interv Cardiol. 2018; 31: 925-931
        • Grigioni F
        • Avierinos JF
        • Ling LH
        • Scott CG
        • Bailey KR
        • Tajik AJ
        • Frye RL
        • Enriquez-Sarano M.
        Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome.
        J Am Coll Cardiol. 2002; 40: 84-92
        • Lapar DJ
        • Speir AM
        • Crosby IK
        • Fonner E
        • Brown M
        • Rich JB
        • Quader M
        • Kern JA
        • Kron IL
        • Ailawadi G
        Investigators for the Virginia Cardiac Surgery Quality Initiative. Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs.
        Ann Thorac Surg. 2014; 98: 527-533
        • Kalavrouziotis D
        • Buth KJ
        • IS Ali
        The impact of new-onset atrial fibrillation on in-hospital mortality following cardiac surgery.
        Chest. 2007; 131: 833-839
        • Mathew JP
        • Fontes ML
        • Tudor IC
        • Ramsay J
        • Duke P
        • Mazer CD
        • Barash PG
        • Hsu PH
        • Mangano DT
        Investigators of the Ischemia Research and Education Foundation, Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery.
        JAMA. 2004; 291: 1720-1729
        • Burrage PS
        • Low YH
        • Campbell NG
        • O'Brien B
        New-onset atrial fibrillation in adult patients after cardiac surgery.
        Curr Anesthesiol Rep. 2019; 9: 174-193
      1. HCUP NRD. Overview. Available at: https://www.hcup-us.ahrq.gov/nrdoverview.jsp. Accessed on January 5, 2022.

      2. HCUP. Elixhauser comorbidity software version 3.7. Available at: https://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp. Accessed on January 5, 2022.

        • Austin SR
        • Wong YN
        • Uzzo RG
        • Beck JR
        • Egleston BL.
        Why summary comorbidity measures such as the Charlson Comorbidity Index and Elixhauser score work.
        Med Care. 2015; 53: e65-e72
        • Gertz ZM
        • Herrmann HC
        • Lim DS
        • Kar S
        • Kapadia SR
        • Reed GW
        • Puri R
        • Krishnaswamy A
        • Gersh BJ
        • Weissman NJ
        • Asch FM
        • Grayburn PA
        • Kosmidou I
        • Redfors B
        • Zhang Z
        • Abraham WT
        • Lindenfeld J
        • Stone GW
        • Mack MJ.
        Implications of atrial fibrillation on the mechanisms of mitral regurgitation and response to MitraClip in the COAP trial.
        Circ Cardiovasc Interv. 2021; 14: 424-432
        • Herrmann HC
        • Gertz ZM
        • Silvestry FE
        • Wiegers SE
        • Woo YJ
        • Hermiller J
        • Segar D
        • Heimansohn D
        • Gray W
        • Homma S
        • Argenziano M
        • Wang A
        • Jollis J
        • Lampert MB
        • Alexander J
        • Mauri L
        • Foster E
        • Glower D
        • Feldman T.
        Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial.
        J Am Coll Cardiol. 2012; 59: 1312-1319
        • Nelson SE
        • Shroff GR
        • Li S
        • Herzog CA.
        Impact of chronic kidney disease on risk of incident atrial fibrillation and subsequent survival in Medicare patients.
        J Am Heart Assoc. 2012; 1e002097
        • Turakhia MP
        • Blankestijn PJ
        • Carrero J-J
        • Clase CM
        • Deo R
        • Herzog CA
        • Kasner SE
        • Passman RS
        • Pecoits-Filho R
        • Reinecke H
        • Shroff GR
        • Zareba W
        • Cheung M
        • Wheeler DC
        • Winkelmayer WC
        • Wanner C
        • Participants C
        • Amann K
        • Banerjee D
        • Bansal N
        • Boriani G
        • Bunch J
        • Chan CT
        • Charytan DM
        • Conen D
        • Friedman AN
        • Genovesi S
        • Holden RM
        • House AA
        • Jadoul M
        • Jardine AG
        • Johnson DW
        • Jun M
        • Labriola L
        • Mark PB
        • McCullough PA
        • Nolin TD
        • Potpara TS
        • Pun PH
        • Ribeiro ALP
        • Rossignol P
        • Shen JI
        • Sood MM
        • Tsukamoto Y
        • Wang AY-M
        • Weir MR
        • Wetmore JB
        • Wranicz JK
        • Yamasaki H.
        Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
        Eur Heart J. 2018; 39: 2314-2325
        • Santhanakrishnan R
        • Wang N
        • Larson MG
        • Magnani JW
        • McManus DD
        • Lubitz SA
        • Ellinor PT
        • Cheng S
        • Vasan RS
        • Lee DS
        • Wang TJ
        • Levy D
        • Benjamin EJ
        • Ho JE.
        Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction.
        Circulation. 2016; 133: 484-492
        • Eguchi K
        • Ohtaki E
        • Matsumura T
        • Tanaka K
        • Tohbaru T
        • Iguchi N
        • Misu K
        • Asano R
        • Nagayama M
        • Sumiyoshi T
        • Kasegawa H
        • Hosoda S.
        Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation.
        Eur Heart J. 2005; 26: 1866-1872
        • Ling LH
        • Enriquez-Sarano M
        • Seward JB
        • Orszulak TA
        • Schaff HVV
        • Bailey KR
        • Tajik AJ
        • Frye RL.
        Early surgery in patients with mitral regurgitation due to flail leaflets: a long-term outcome study.
        Circulation. 1997; 96: 1819-1825
        • Maor E
        • Raphael CE
        • Panaich SS
        • Reeder GS
        • Nishimura RA
        • Nkomo VT
        • Rihal CS
        • Eleid MF.
        Acute changes in left atrial pressure after MitraClip are associated with improvement in 6-minute walk distance.
        Circ Cardiovasc Interv. 2017; 10e004856
        • Detaint D
        • Sundt TM
        • Nkomo VT
        • Scott CG
        • Tajik AJ
        • Schaff HV v.
        • Enriquez-Sarano M.
        Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements.
        Circulation. 2006; 114: 265-272
        • Remadi JP
        • Baron O
        • Roussel C
        • Bizouarn P
        • Habasch A
        • Despins P
        • Michaud JL
        • Duveau D.
        Isolated mitral valve replacement St. Jude medical prosthesis: Long-term results: a follow-up of 19 years.
        Circulation. 2001; 103: 1542-1545
        • Siegel RJ
        • Biner S
        • Rafique AM
        • Rinaldi M
        • Lim S
        • Fail P
        • Hermiller J
        • Smalling R
        • Whitlow PL
        • Herrmann HC
        • Foster E
        • Feldman T
        • Glower D
        • Kar S
        • Investigators EVEREST
        The acute hemodynamic effects of MitraClip therapy.
        J Am Coll Cardiol. 2011; 57: 1658-1665
        • Echahidi N
        • Pibarot P
        • O'Hara G
        • Mathieu P
        Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery.
        J Am Coll Cardiol. 2008; 51: 793-801